India’s nutraceutical landscape is experiencing a transformative phase, driven by heightened consumer awareness about preventive health and a rapidly expanding wellness economy. As the sector matures, platforms that facilitate meaningful industry connections, knowledge exchange, and business development have become essential for manufacturers seeking to establish their position in this competitive market. Trade exhibitions serve as catalysts for innovation, enabling companies to showcase technical capabilities, forge strategic partnerships, and gain insights into emerging trends shaping the future of nutritional science.

Vitafoods India 2026: India’s Premier Nutraceutical Platform

Scheduled from February 11-13, 2026, at the Jio World Convention Centre in Mumbai, Vitafoods India has established itself as the country’s foremost exhibition dedicated to nutraceuticals, functional foods, and dietary supplements. The 2026 edition anticipates over 10,000 trade visitors, more than 200 exhibitors spanning domestic and international markets, and insights from 40+ industry experts across knowledge-sharing sessions.

What distinguishes Vitafoods India is its dual focus on commercial opportunity and intellectual advancement. The event features dedicated zones for live product demonstrations, interactive ingredient showcases, and expert dialogues addressing critical themes including personalized nutrition, clean-label formulations, and regulatory frameworks. Conference sessions will examine “Nutraceuticals 2030: Science, Standards, and Scale for India’s Global Significance,” reflecting the industry’s trajectory toward international competitiveness and scientific rigor.

H&H Healthcare’s Strategic Return

H&H Healthcare and Cosmetics Pvt. Ltd. returns to Vitafoods India 2026 for its second consecutive participation, occupying Stall H28 in Pavilion 2. This continued presence reflects the company’s strategic commitment to industry engagement and partnership development within India’s expanding nutraceutical ecosystem. The company’s exhibition will be led by key leadership including Mr. Vaibhaav Rai, Founder and Chief Managing Director, Mr. Harshul Rai, Managing Director and Chief Financial Officer, and senior human resources leadership.

This executive-level participation signals H&H Healthcare’s serious approach to relationship building and strategic business discussions—recognizing that meaningful partnerships emerge from substantive conversations between decision-makers rather than purely transactional interactions.

Manufacturing Excellence and Technical Capabilities

As a nutraceutical contract manufacturing company in India, H&H Healthcare brings significant technical depth to the exhibition. Established in 2021, the company has rapidly developed comprehensive manufacturing capabilities spanning multiple dosage forms including powders, tablets, capsules, and softgels. The facility operates 11 advanced, fully automated packaging lines, demonstrating production capacity and quality systems that meet international manufacturing standards.

The company’s November 2025 inauguration of a state-of-the-art facility developed through strategic association with Herbalife International represents a watershed moment in Indian nutraceutical manufacturing. This facility incorporates advanced granulation and blending systems, precision tablet compression machinery, high-speed packaging infrastructure, dedicated R&D-driven formulation units, and a 1.3 lakh square foot warehousing facility.

The facility investment, exceeding ₹50 crore, reflects H&H Healthcare’s long-term commitment to technological advancement. By the end of 2026, the company plans to commence production in ready-to-drink formulations, gummies, spray-dried products, and advanced blending facilities—expanding its service portfolio to address diverse market segments and emerging consumer preferences.

Strategic Objectives at Vitafoods India 2026

H&H Healthcare’s participation serves multiple strategic objectives beyond brand visibility. The exhibition provides a concentrated platform for direct engagement with potential partners across the nutraceutical value chain—ingredient suppliers seeking manufacturing partnerships, wellness brands requiring production capabilities, distributors evaluating product portfolios, and international companies exploring 

India’s manufacturing landscape.

The company’s association with Herbalife International—a globally recognized wellness company operating in over 90 markets—provides compelling validation of H&H Healthcare’s manufacturing standards and quality systems. At Stall H28, visitors can expect substantive discussions about technical capabilities, quality assurance protocols, regulatory compliance frameworks, and production scaling potential.

The exhibition also serves as an intelligence-gathering platform, enabling H&H Healthcare’s leadership to assess competitive positioning, understand emerging ingredient trends, evaluate technological innovations, and gain insights into regulatory developments affecting the sector. This market intelligence informs strategic planning and ensures the company’s development trajectory aligns with industry evolution.

India’s Expanding Role in Global Manufacturing

H&H Healthcare’s growth trajectory mirrors broader dynamics transforming India’s position within global wellness manufacturing. The country offers distinct advantages including established pharmaceutical manufacturing expertise, cost-competitive production capabilities, improving regulatory infrastructure through authorities like FSSAI, and a growing pool of technical talent experienced in formulation science and quality systems.

The “Make in India” initiative has catalyzed significant investment in manufacturing infrastructure, encouraging both domestic companies and international partners to establish or expand production facilities. For contract manufacturers, this creates substantial opportunity—global wellness brands increasingly seek manufacturing partners who can deliver quality, scalability, and regulatory compliance while offering favorable economics.

H&H Healthcare’s facility development exemplifies how Indian manufacturers are closing the capability gap with international counterparts. The integration of advanced technology, adherence to stringent quality protocols, and commitment to continuous improvement positions companies like H&H Healthcare as viable partners for brands with exacting standards.

Conclusion

As India’s nutraceutical industry transitions from emerging market to established sector, platforms facilitating meaningful industry dialogue intensify in importance. Vitafoods India 2026 represents such a convergence point—where innovation meets opportunity, where technical capabilities encounter market demand, and where relationships form that shape the sector’s trajectory.

H&H Healthcare’s return to this platform reflects maturity in approach and confidence in capability. The company’s journey from 2021 establishment to strategic partnership with global wellness leaders demonstrates what becomes possible when technical excellence meets ambitious vision. As industry professionals visit Stall H28, they will find not merely another manufacturer but a partner genuinely invested in advancing India’s role within global wellness manufacturing—a company whose commitment to quality, innovation, and collaborative success is firmly established.

Event Details:

Vitafoods India 2026

February 11-13, 2026

Pavilion 2, Stall H28

Jio World Convention Centre, Mumbai

10:00 AM – 6:00 PM (Feb 11-12) | 10:00 AM – 5:00 PM (Feb 13)

Visit H&H Healthcare –

Discover how H&H Healthcare and Cosmetics Pvt. Ltd. is shaping the future of nutraceutical contract manufacturing in India. Schedule a meeting with our leadership team at Stall H28.

About H&H Healthcare and Cosmetics Pvt. Ltd.

Established in 2021, H&H Healthcare and Cosmetics Pvt. Ltd. specializes in premium healthcare, nutraceutical, and personal care manufacturing. With state-of-the-art facilities in Indore, Madhya Pradesh, and strategic partnerships with global wellness leaders, the company delivers quality, innovation, and reliability across domestic and international markets.